Design and Application of a Home Care WeChat Mini-Program for Children After Congenital Heart Disease Surgery

Starting soon · Not applicable

Conditions studied: Congenital Heart Disease

In brief

This is a single-blind, randomized controlled trial aimed at evaluating the effectiveness of a family-centered, WeChat-based home care mini-program for children after congenital heart disease (CHD) surgery. Given the chronic nature of post-operative CHD management and the significant stress placed on families, this study shifts from a deficit-based to a strengths-based perspective, guided by the Double ABC-X model. Children (≤12 years old) who have undergone CHD surgery and their primary caregivers will be recruited. Participants will be randomly assigned to either the intervention group, which uses the mini-program for health education, peer support, and physiological monitoring, or the control group, which receives routine telephone follow-up. The primary outcomes are family health (measured by the Family Health Scale), family stress, and the quality of life for both the child and caregivers. Secondary outcomes include physiological parameters such as the 6-minute walk test distance. The study aims to provide evidence for a scalable digital health intervention to support long-term family adaptation and child recovery.

Key facts

Study ID

NCT07385209

Run by

ruijie YangLan

People needed

210

Starts

2026-03-30

Expected to finish

2027-03-30

Last updated by the study team

2026-02-04

Who can join

Age: any, up to 12. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• - The child is ≤12 years old.
• The child has been diagnosed with congenital heart disease (CHD) and is scheduled for or has undergone corrective surgery.
• The child is in a stable medical condition (non-acute phase).
• At least one primary caregiver (parent or sibling >12 years old) of the child agrees to participate.
• The caregiver provides written informed consent to participate in the study.

You may not qualify if…

• - The child has severe developmental defects.
• The child has other major diseases that significantly affect quality of life.
• The caregiver has visual, hearing, or cognitive impairments that hinder communication.
• The caregiver has a diagnosed psychiatric disorder.
• The caregiver is unconscious or otherwise unable to provide consent.

Where it is running

• First Affiliated Hospital of Kunming Medical University — Kunming, Yunnan, China

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.